Concepedia

Shrila Rajendran

SR

Statistics

Publications

7

Citations

202

H-Index

7

Active since

2019

Affiliations

University of Michigan(Current)

Michigan Medicine

BioSurfaces (United States)

University of California San Diego

Shrila Rajendran is an author at University of Michigan specializing in oncology, cell biology, and molecular oncology.

ORCID

Publications per year

2019–2024

7

Publications

7

Plasminogen Activator Inhibitor 1 (PAI1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast Cancer

Brock A. Humphries, Johanna M. Buschhaus, Yu‐Chih Chen et al. · Molecular Cancer Research · 2019 · 80 citations · Full text

, , +17

Targeting disseminated estrogen-receptor-positive breast cancer cells in bone marrow

Johanna M. Buschhaus, Brock A. Humphries, Samantha S. Eckley et al. · Oncogene · 2020 · 34 citations · Full text

, , +14

Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer

Johanna M. Buschhaus, Shrila Rajendran, Brock A. Humphries et al. · Oncogene · 2022 · 30 citations · Full text

, , +16

Enhanced mitochondrial fission inhibits triple-negative breast cancer cell migration through an ROS-dependent mechanism

Brock A. Humphries, Anne Zhang, Johanna M. Buschhaus et al. · iScience · 2023 · 23 citations · Full text

, , +17

Bone Marrow Mesenchymal Stem Cells Induce Metabolic Plasticity in Estrogen Receptor–Positive Breast Cancer

Johanna M. Buschhaus, Shrila Rajendran, Siyi Chen et al. · Molecular Cancer Research · 2023 · 13 citations · Full text

, , +17

1–5 of 7